Dry Eye Support Complex.

Long-chain omega-3 fatty acids are incorporated into the oily secretion that forms the outer layer of the tear film, changing its melt behaviour and how quickly the film thins between blinks. That is the mechanistic reason omega-3 sits at the centre of most ocular surface comfort formulas.

EPA competes with arachidonic acid for the same oxygenase enzymes, shifting the local mediator profile at the ocular surface toward less irritating species. It also alters the fatty acid make-up of the lid gland secretion.

DHA is the dominant long-chain fatty acid in retinal and corneal nerve membranes, so it supports the tissue side of surface sensation while EPA works on the mediator side. The two are typically dosed together for that reason.

GLA enters the omega-6 chain past the slow delta-6 desaturase step and elongates to dihomo-gamma-linolenic acid, which feeds the series-1 mediator route rather than the arachidonic acid route. Pairing it with omega-3 covers both fatty acid families at once.

Borage supplies the same GLA as evening primrose at roughly twice the concentration, so it is the usual choice when a formula needs a meaningful GLA dose in a small softgel. The fatty acid route is identical.

Black currant seed oil carries GLA alongside a small amount of stearidonic acid, which enters the omega-3 chain past the same rate-limiting desaturase. That gives it a foot in both fatty acid families in one oil.

Retinoids govern the differentiation of conjunctival goblet cells, the cells that secrete the mucins holding the watery layer against the eye surface. Without adequate vitamin A that mucin layer does not form normally.

Zinc is needed to make retinol-binding protein, the carrier that moves vitamin A out of the liver into circulation. Low zinc leaves vitamin A stranded in storage no matter how much is taken.

Lactoferrin is one of the abundant proteins secreted into normal tears, where it binds free iron and supports the antimicrobial character of the film. It is a direct compositional partner rather than an indirect one.

Taurine is one of the most concentrated free amino acids in the retina and corneal epithelium, where it acts as an osmolyte that helps cells hold volume against a salty surface. That role is complementary to fatty acid work on the tear film itself.

The long-chain unsaturated oils in this category oxidise readily, and tocopherol is the standard chain-breaking antioxidant added to keep them intact in the capsule and in the body. It is formulation practice with a settled chemical basis.

Ascorbate reduces the tocopheryl radical back to tocopherol at the water and lipid boundary, so the vitamin E protecting the oils is recycled rather than spent once. The pairing is the classic antioxidant relay.

Astaxanthin sits across the lipid bilayer with polar ends at both surfaces, which lets it quench radicals in the membrane interior and at the water boundary. In eye formulas it is paired with omega-3 to protect those same membrane fats.

Alpha-linolenic acid from flax converts to EPA at a low and variable rate through the same desaturase and elongase steps. It is the plant-based route to the same tear film lipid effect and is usually dosed higher for that reason.

Hyaluronic acid is a water-binding glycosaminoglycan used topically in ocular lubricants and studied orally for hydration of other epithelial and connective tissue. An oral sodium hyaluronate trial reported changes in skin hydration and barrier measures, which is a different tissue from the ocular surface and should not be read across. In a blend it is included on the water-retention rationale. The oral-to-eye link is mechanistic rather than demonstrated.

Lutein concentrates selectively in retinal tissue and filters short-wavelength light, a different job from tear film support. Ocular blends usually carry both a tear-film lipid component and a macular carotenoid because they cover separate parts of normal eye function. Adding lutein does not change tear film behaviour. It broadens what the formula supports rather than reinforcing one mechanism.

Zeaxanthin sits with lutein and meso-zeaxanthin in the macular pigment and is absorbed on the same lipid-dependent route as other carotenoids. It is paired with lutein at conventional ratios in most ocular formulas. Its contribution is to macular pigment optical density, a marker, not to tear production.

Krill oil delivers EPA and DHA partly bound to phospholipid rather than as triglyceride, which changes how the fatty acids are handled during digestion. Phospholipid-bound omega-3 has been of interest in ocular formulas because the tear film lipid layer is itself a phospholipid and wax ester mixture. Head to head evidence against triglyceride omega-3 for ocular endpoints is thin. Read the difference as a delivery-chemistry question.

Sea buckthorn pulp oil is unusual in carrying a high proportion of palmitoleic acid, a fatty acid present in meibomian secretions. It has been used orally in Nordic and Central Asian practice for mucous membrane comfort. It appears in ocular blends on that compositional logic. The supporting human work is small and the rationale is largely compositional.

Vitamin D receptors are present in corneal and conjunctival epithelium and in the lacrimal gland, and calcitriol influences epithelial barrier proteins in those tissues. Observational work has linked vitamin D status with tear film measures, which is an association and not a demonstrated cause. Blends include it on that basis. The reading should stay at status and marker level.

Riboflavin is the precursor of FAD, the flavin cofactor glutathione reductase needs to regenerate reduced glutathione. Corneal and conjunctival epithelium depend on that recycling to keep their normal redox state. A B vitamin review of ocular health covers this pathway. The cofactor relationship is textbook; the ocular endpoint work is narrative.

Cobalamin is the cofactor for methionine synthase and for methylmalonyl-CoA mutase, and its status governs myelin maintenance in peripheral nerve including the corneal nerve plexus. Corneal nerve density is one of the measures used in ocular surface research. A B vitamin ocular review names this link. Corneal nerve morphology is a marker and not a symptom outcome.

Quercetin stabilises mast cell membranes in laboratory systems and inhibits histamine release, which is why it appears in formulas aimed at ocular comfort in dusty or allergen-heavy settings. Most of that work is in vitro or in animals. Human ocular endpoint data specific to quercetin are limited.

The carotenoids and vitamins A, D and E in an ocular blend are all fat soluble and need a lipid phase for micellar uptake. Softgel formats supply that lipid directly; powder and tablet formats do not, which is why they are usually taken with a meal. MCT is one carrier used for the purpose. The relationship is absorption only.

Glutathione peroxidase is a selenoenzyme, so selenium status sets the ceiling on how fast peroxides are cleared using glutathione. That pathway works alongside vitamin E, which handles lipid peroxyl radicals in membranes. Ocular blends that carry vitamin E often carry selenium for this reason. Selenium has a narrow intake range and stacking multiple products can push total intake high.

Interest in a gut-to-ocular-surface axis comes largely from animal models and small human pilot work looking at commensal composition and tear film measures. No settled mechanism connects a specific strain to a tear film endpoint. Anything here is exploratory and should be labelled that way.